Professor Cliff Bailey and Professor Vinod Patel discuss type 2 diabetes and SGLT2 inhibitors in context plus managing glycaemic control and body weight.
Professor Cliff Bailey and Dr Martin Hadley-Brown discuss the effects of SGLT2 inhibitors on cardiovascular function and their role in the management of CV disease.
Professor Cliff Bailey and Dr Pam Brown discuss the reno-protective effects of SGLT2 inhibitors and their role in the management diabetic kidney disease.
A new NHS service to provide a non-surgical reversible weight loss device for people who have both poorly controlled type 2 diabetes and obesity is safe and effective and should be rolled out across the NHS, according to new research presented at the recent EASD annual meeting in Lisbon, Portugal.
An update of the QOF indicator list by NICE suggests that eight new diabetes indicators should be added to QOF from 2019/20. NICE says that the new approach, which comes following a review of the QOF in England, will improve outcomes and decrease the risk of harm from over-treatment.
The online medical learning company The Sound Doctor has launched a new diabetes library which adds to its existing website-based collection of short films for patients.
In May 2009, NICE published recommendations on the use of newer agents for the control of blood glucose in type 2 diabetes. This guideline provides a partial update for NICE Clinical Guideline 66 on the management of type 2 diabetes that was published last year. These newer agents include the dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones (TZDs), the glucagon-like peptide-1 (GLP-1) mimetic exenatide and the long-acting insulin analogues (insulin detemir and insulin glargine).
The Royal College of General Practitioners (RCGP) has released an online course exploring low glycaemic-index (GI) diets in type 2 diabetes. The 30-minute e-learning module ‘Type 2 Diabetes – a Low GI Approach’ is aimed at GPs, practice nurses, diabetes specialists nurses and other healthcare professionals working in primary care interested in helping people living with type 2 diabetes.